Completed PHASE1 INTERVENTIONAL 1-arm NCT01826240

Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior

Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior: A Treatment Development Study

Sponsor: American Foundation for Suicide Prevention

Conditions Monopolar Depression, Single Episode or Unspecified Suicidal and Self-injurious Behaviour

Interventions MBCT+SPI

Updated 5 times since 2017 Last updated: Dec 3, 2015 Started: Mar 31, 2013 Primary completion: Feb 28, 2015 Completion: Feb 28, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01826240, this PHASE1 trial focuses on Monopolar Depression, Single Episode or Unspecified and Suicidal and Self-injurious Behaviour and remains completed. Sponsored by American Foundation for Suicide Prevention, it has been updated 5 times since 2013, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Mar 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Foundation for Suicide Prevention
New York State Psychiatric Institute

Data source: New York State Psychiatric Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States